Abstract: This invention provides thiazolylpiperazine derivatives, and N-sulfonyl heterocyclic derivatives including phenyl- and benzyl-thiazolylpiperidine derivatives, and pharmaceutically acceptable salts thereof, which are useful active ingredients for administration in a method for the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides methods for making such derivatives, and pharmaceutical compositions including such derivatives together with pharmaceutically acceptable excipients.
Type:
Grant
Filed:
February 5, 2010
Date of Patent:
May 13, 2014
Assignee:
NV reMYND
Inventors:
Gerard Griffioen, Veronica Rojas De La Parra, Annick Lauwers
Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
Type:
Grant
Filed:
August 6, 2008
Date of Patent:
September 24, 2013
Assignee:
NV reMYND
Inventors:
Gerard Griffioen, Kristel Marie Edith Coupet, Hein Roger Duhamel, Stefaan Wera, Ellen Gommé, Nele Van Damme, Ingrid Van Der Auwera, Marleen Lox, Tom Van Dooren, Tine Decruy
Abstract: The invention provides novel 1,2,4-thiadiazole derivatives useful for preventing or treating an ?-synucleopathy such as Parkinson's disease, as well as pharmaceutical compositions including them as biologically active ingredients, and methods for manufacturing them.
Type:
Grant
Filed:
November 22, 2007
Date of Patent:
June 14, 2011
Assignee:
NV reMYND
Inventors:
Gerard Griffioen, Stefaan Wera, Hein Roger Duhamel, Ellen Gommé, Nele Van Damme
Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
Type:
Application
Filed:
August 6, 2008
Publication date:
October 14, 2010
Applicant:
NV reMYND
Inventors:
Gerard GRIFFIOEN, Kristel Marie Edith COUPET, Hein Roger DUHAMEL, Stefaan WERA, Ellen GOMME, Nele VAN DAMME, Ingrid VAN DER AUWERA, Marleen LOX, Tom VAN DOOREN, Tine DECRUY
Abstract: This invention provides thiazolylpiperazine derivatives, and N-sulfonyl heterocyclic derivatives including phenyl- and benzyl-thiazolylpiperidine derivatives, and pharmaceutically acceptable salts thereof, which are useful active ingredients for administration in a method for the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides methods for making such derivatives, and pharmaceutical compositions including such derivatives together with pharmaceutically acceptable excipients.
Type:
Application
Filed:
February 5, 2010
Publication date:
August 5, 2010
Applicant:
NV reMYND
Inventors:
Gerard GRIFFIOEN, Veronica ROJAS DE LA PARRA, Annick LAUWERS
Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
Type:
Application
Filed:
August 6, 2008
Publication date:
September 17, 2009
Applicant:
NV reMYND
Inventors:
Gerard GRIFFIOEN, Kristel Marie Edith COUPET, Hein Roger DUHAMEL, Stefaan WERA, Ellen GOMMÉ, Nele VAN DAMME, Ingrid VAN DER AUWERA, Marleen LOX, Tom VAN DOOREN, Tine DECRUY
Abstract: The present invention relates in general to the fields of chemical, pharmaceutical and genetic screening and to diseases associated with protein misfolding. In particular, it discloses engineered cells and a system based thereon that can be used to screen for substances that affect protein misfolding. The engineered cells of the invention comprise one or more reporter genes under transcriptional control of a promoter that is responsive to protein misfolding.
Type:
Application
Filed:
June 1, 2007
Publication date:
July 23, 2009
Applicant:
NV reMYND
Inventors:
Gerard Griffioen, Kristel Marie Edith Coupet, Nele Van Damme, Stefaan Wera
Abstract: This invention provides specifically substituted 1,2,4-thiadiazole derivatives for use in the treatment of an ?-synucleopathy such as Parkinson's disease, diffuse Lewy body disease, traumatic brain injury, amyotrophic lateral sclerosis, Niemann-Pick disease, Hallervorden-Spatz syndrome, Down syndrome, neuroaxonal dystrophy, multiple system atrophy and Alzheimer's disease. This invention also provides various methods for producing such substituted 1,2,4-thiadiazole derivatives.
Type:
Application
Filed:
August 6, 2008
Publication date:
February 26, 2009
Applicant:
NV reMYND
Inventors:
Gerard GRIFFIOEN, Kristel Marie Edith COUPET, Hein Roger DUHAMEL, Stefaan WERA, Ellen GOMME, Nele VAN DAMME, Ingrid VAN DER AUWERA, Marleen LOX, Tom VAN DOOREN, Tine DECRUY